Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OrderlyMeds vs PrideRx

OrderlyMeds
Graded #78

Higher grade

vs+16.700000000000003
PrideRx
Graded #434

Lower grade

The verdict

OrderlyMeds takes it — 72.4/100 to 55.7/100.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +72
92
20
Dose & formulationPrideRx +19
64
83
Clinical oversightOrderlyMeds +8
82
74
Labs & monitoringEven
53
53
FulfillmentPrideRx +2
65
67
Contract termsOrderlyMeds +14
55
41
OrderlyMeds · left barPrideRx · right bar

The numbers

MetricOrderlyMedsPrideRx
WeighScore72.4/10055.7/100
GradeCC
Scorecard rank#78#434
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)$149/mo (starting dose, plus a separate fee, brand-name)
Tirzepatide$299/mo (compounded)$299/mo (2.5 mg dose, plus a separate fee, brand-name)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
PrideRx

Graded #434 · C

Strengths

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

Where it loses points

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard